These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38375481)

  • 41. Multicentric clinical and epidemiological comparison of neuromyelitis optica spectrum disorder with multiple sclerosis from India.
    Gupta S; Rehani V; Acharya R; Purohit P; Anadure R; Ahmad F; Soni R; Gupta A; Hiremath R
    Mult Scler Relat Disord; 2021 Jan; 47():102616. PubMed ID: 33166808
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eye movement abnormalities in AQP4-IgG positive neuromyelitis optica spectrum disorder.
    Sun H; Cui S; Gao F; You Q; Li Y; Wang J; Zhang X
    J Neurol Sci; 2018 Jan; 384():91-95. PubMed ID: 29249386
    [TBL] [Abstract][Full Text] [Related]  

  • 43. White Matter Network Disruption and Cognitive Dysfunction in Neuromyelitis Optica Spectrum Disorder.
    Cho EB; Han CE; Seo SW; Chin J; Shin JH; Cho HJ; Seok JM; Kim ST; Kim BJ; Na DL; Lee KH; Seong JK; Min JH
    Front Neurol; 2018; 9():1104. PubMed ID: 30619061
    [No Abstract]   [Full Text] [Related]  

  • 44. Impact of psychiatric distress and physical disability on quality of life in neuromyelitis optica spectrum disorder and chronic autoimmune demyelinating polyneuropathies.
    Yalachkov Y; Soydaş D; Uhlmann V; Behrens M; Frisch S; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2021 Feb; 48():102711. PubMed ID: 33383364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions.
    Mealy MA; Mossburg SE; Kim SH; Messina S; Borisow N; Lopez-Gonzalez R; Ospina JP; Scheel M; Yeshokumar AK; Awad A; Leite MI; Arango JJ; Paul F; Palace J; Kim HJ; Levy M
    Mult Scler Relat Disord; 2019 Feb; 28():64-68. PubMed ID: 30554040
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Structural covariance in subcortical regions in multiple sclerosis and neuromyelitis optica spectrum disorders: An MRI-based study with automated brain volumetry.
    Xie Y; Zhang Y; Yao Y; Liu D; Zhu H; Liu C; Zhu W
    Mult Scler Relat Disord; 2023 Feb; 70():104516. PubMed ID: 36669244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression and Clinical Correlation Analysis Between Repulsive Guidance Molecule a and Neuromyelitis Optica Spectrum Disorders.
    Tang J; Zeng X; Yang J; Zhang L; Li H; Chen R; Tang S; Luo Y; Qin X; Feng J
    Front Immunol; 2022; 13():766099. PubMed ID: 35185873
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Visual system damage and network maladaptation are associated with cognitive performance in neuromyelitis optica spectrum disorders.
    Chavarro VS; Bellmann-Strobl J; Zimmermann HG; Scheel M; Chien C; Oertel FC; Weygandt M; Ruprecht K; Paul F; Finke C; Brandt AU
    Mult Scler Relat Disord; 2020 Oct; 45():102406. PubMed ID: 32707533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuromyelitis optica spectrum disorders with a benign course. Analysis of 544 patients.
    Lana-Peixoto MA; Talim NC; Callegaro D; Marques VD; Damasceno A; Becker J; Gonçalves MVM; Sato H;
    Mult Scler Relat Disord; 2023 Jul; 75():104730. PubMed ID: 37156036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Widespread cortical thinning in patients with neuromyelitis optica spectrum disorder.
    Kim SH; Kwak K; Hyun JW; Jeong IH; Jo HJ; Joung A; Kim JH; Lee SH; Yun S; Joo J; Lee JM; Kim HJ
    Eur J Neurol; 2016 Jul; 23(7):1165-73. PubMed ID: 27108769
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Irregular degree centrality in neuromyelitis optica spectrum disorder patients with optic neuritis: A resting-state functional magnetic resonance imaging study.
    Wei R; Yan J; Wu H; Meng F; He F; Liu X; Liang H
    Mult Scler Relat Disord; 2022 Mar; 59():103542. PubMed ID: 35091366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical characteristics and follow-up of pediatric patients with neuromyelitis optica and neuromyelitis optica spectrum disorders].
    Yun W; Weihua Z; Xiaotun R; Jiuwei L; Xinying Y; Junlan L; Changhong D; Chunhong C; Haitao R; Liying C; Fang F
    Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):268-73. PubMed ID: 26182501
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional connectivity dynamics reflect disability and multi-domain clinical impairment in patients with relapsing-remitting multiple sclerosis.
    Romanello A; Krohn S; von Schwanenflug N; Chien C; Bellmann-Strobl J; Ruprecht K; Paul F; Finke C
    Neuroimage Clin; 2022; 36():103203. PubMed ID: 36179389
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of dysautonomic symptom burden on the quality of life in Neuromyelitis optica spectrum disorder patients.
    Yang L; Li W; Xie Y; Ma S; Zhou X; Huang X; Tan S
    BMC Neurol; 2023 Mar; 23(1):112. PubMed ID: 36941592
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Personalized estimates of morphometric similarity in multiple sclerosis and neuromyelitis optica spectrum disorders.
    Sun J; Zhao W; Xie Y; Zhou F; Wu L; Li Y; Li H; Li Y; Zeng C; Han X; Liu Y; Zhang N
    Neuroimage Clin; 2023; 39():103454. PubMed ID: 37343344
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Health-related quality of life in neuromyelitis optica spectrum disorder patients in an Argentinean cohort.
    Carnero Contentti E; Eizaguirre MB; López PA; Rojas JI; Tkachuk V; Alonso R
    Mult Scler Relat Disord; 2022 Mar; 59():103647. PubMed ID: 35124305
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum levels of cell adhesion molecules in patients with neuromyelitis optica spectrum disorder.
    Chang BL; Ro LS; Chen CM; Lo YS; Lyu RK; Kuo HC; Liao MF; Chang CW; Chang HS; Huang CC; Wu YR; Chu CC; Weng YC; Chang KH
    Ann Clin Transl Neurol; 2020 Oct; 7(10):1854-1861. PubMed ID: 32860355
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Neutrophil-to-Lymphocyte Ratio and the Monocyte-to-Lymphocyte Ratio Predict Expanded Disability Status Scale Score at One Year in Pediatric Neuromyelitis Optica Spectrum Disorder but not in Multiple Sclerosis.
    Devlin L; Gombolay G
    Pediatr Neurol; 2023 Jun; 143():84-88. PubMed ID: 37044044
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impaired structural and reserved functional topological organizations of brain networks in Parkinson's disease with freezing of gait.
    Wang L; Gan C; Sun H; Ji M; Zhang H; Cao X; Wang M; Yuan Y; Zhang K
    Quant Imaging Med Surg; 2023 Jan; 13(1):66-79. PubMed ID: 36620158
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The nutritional risk in patients with neuromyelitis optica spectrum disorder.
    Huang R; Huang X; Wang Y; Xie Y; Chen K; Ma S; Zhou X; Li W; Tan S; Yang L
    Mult Scler Relat Disord; 2023 Sep; 77():104900. PubMed ID: 37487344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.